1.
Haematologica
; 90(1): 129-31, 2005 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15642681
RESUMO
Eighty-nine thalassemic patients with chronic hepatitis C were treated with interferon alpha-2a for 12 months and followed up for 8 years. Interferon induced sustained virologic and biochemical response in 45% of participants and histologic improvement in 50% of patients who had paired liver biopsies. Splenectomy was the only independent predictor of an unfavorable outcome.